Future research should incorporate comprehensive protein‐level assessments of PERK, ATF6, IRE1α, CHOP, and associated effectors to reinforce the in silico and in vitro findings and to elucidate the modulatory effects of 4‐PBA on ER‐stress within colon cancer models. This evidence concerns the gene ATF6 and malignant colon neoplasm.